4//SEC Filing
Bachleda Mark 4
Accession 0000899243-23-009095
CIK 0001563577other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 4:05 PM ET
Size
5.1 KB
Accession
0000899243-23-009095
Insider Transaction Report
Form 4
Bachleda Mark
Chief Commercial Officer
Transactions
- Purchase
Common Stock
2023-03-16$2.25/sh+11,000$24,717→ 11,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.21 to $2.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
Galera Therapeutics, Inc.
CIK 0001563577
Entity typeother
Related Parties
1- filerCIK 0001887762
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 4:05 PM ET
- Size
- 5.1 KB